The emergence of non‐hypervascular hypointense nodules on enhanced MRI in patients with chronic hepatitis C

The emergence of non‐hypervascular hypointense nodules on enhanced MRI in patients with chronic hepatitis C:

Summary

Background

Intrahepatic non‐hypervascular hypointense nodules (NHHNs) detected during the hepatobiliary phase of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging (EOB‐MRI) have the potential to transition into typical hypervascular hepatocellular carcinoma (HCC). However, the incidence and risk factors for the emergence of these nodules in patients with chronic hepatitis C virus (HCV) infection are unknown.

Aim

To investigate the incidence and risk factors for NHHNs in patients with chronic HCV infection in a longitudinal follow‐up study

Methods

EOB‐MRI was performed in 608 patients with chronic HCV infection and no history of HCC. The characteristics of patients with and without NHHNs were compared. In patients without NHHNs at baseline, the incidence of NHHN emergence and associated risk factors were analysed.

Results

NHHNs were detected at baseline in 93 of 608 patients (15.3%). Among 515 patients without NHHNs at baseline, the 1‐year, 3‐year and 5‐year incidence of NHHN emergence was 1.8%, 9.8% and 16.4%, respectively. Only FIB‐4 index was independently associated with the emergence of NHHNs in multivariate analyses. Whereas NHHNs emerged in 24.1% of patients with FIB‐4 index ≥ 3.25 at 5 years, none emerged in patients with FIB‐4 index < 1.45.

Conclusion

In patients with chronic HCV infection, advanced liver fibrosis is an important risk factor for the presence or emergence of NHHNs.